BOLOGNESI, ANDREA
BOLOGNESI, ANDREA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
(ClO4)2: Metallodrug Nanocontainer Delivery and Membrane Lipidomics of a Neuroblastoma Cell Line Coupled with a Liposome Biomimetic Model Focusing on Fatty Acid Reactivity
2018 Toniolo, Gianluca; Louka, Maria; Menounou, Georgia; Fantoni, Nicolò Zuin; Mitrikas, George; Efthimiadou, Eleni K.; Masi, Annalisa; Bortolotti, Massimo; Polito, Letizia; Bolognesi, Andrea; Kellett, Andrew; Ferreri, Carla; Chatgilialoglu, Chryssostomos
A new potent and selective anti-lymphocytes-immunotoxin for the treatment of GVHD and lymphocyte-derived neoplasms
2009 Polito L.; Bortolotti M.; Pedrazzi M.; Farini V.; Bolognesi A.
A systemic antiviral resistance-inducing protein isolated from Clerodendrum inerme Gaertn. is a polynucleotide:adenosine glycosidase (ribosome-inactivating protein)
1996 Olivieri F.; Prasad V.; Valbonesi P.; Srivastava S.; Ghosal-Chowdhury P.; Barbieri L.; Bolognesi A.; Stirpe F.
Activities associated with the presence of ribosome-inactivating proteins increase in senescent and stressed leaves
1996 Stirpe F.; Barbieri L.; Gorini P.; Valbonesi P.; Bolognesi A.; Polito L.
An epstein-barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins
1999 Tazzari P.L.; De Totero D.; Bolognesi A.; Testoni N.; Pileri S.; Roncella S.; Reato G.; Stein H.; Gobbi M.; Stirpe F.
Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice
1996 Terenzi A.; Bolognesi A.; Pasqualucci L.; Flenghi L.; Pileri S.; Stein H.; Marshall K.; Bigerna B.; Polito L.; Tazzari P.L.; Martelli M.F.; Stirpe F.; Falini B.
Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?
2022 Zanello A.; Bortolotti M.; Maiello S.; Bolognesi A.; Polito L.
Anti-tumor activity of Epratuzumab/saporin-S6.
2012 Bortolotti M.; Polito L; Farini V; Pedrazzi M; Battelli MG; Bolognesi A.
Antibody conjugates for sarcoma therapy: How far along are we?
2021 Polito L.; Calafato G.; Bortolotti M.; Chiarelli Olivari C.; Maiello S.; Bolognesi A.
Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1
2016 Polito, Letizia; Bortolotti, Massimo; Pedrazzi, Manuela; Mercatelli, Daniele; Battelli, Maria Giulia; Bolognesi, Andrea
Assessing potential health threats by monitoring poison control centre data: a new alert in Italy concerning toxic concentrations of ricin in fertilizers
2019 Franca Davanzo; Andrea Bolognesi; Laura Settimi
ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells.
2009 Polito L.; Bortolotti M.; Farini V.; Pedrazzi M.; Tazzari P.L.; Bolognesi A.
B-b10 (Anti-CD25)-saporin immunotoxin—a possible tool in graft-versus-host disease treatment1
1992 Tazzari P.L.; Bolognesi A.; De Totero D.; Pileri S.; Conte R.; Wijdenes J.; Herve P.; Soria M.; Stirpe F.; Gobbi M.
B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease
1997 Vooijs W.C.; Otten H.G.; Van Vliet M.; Van Dijk A.J.G.; De Weger R.A.; De Boer M.; Bohlen H.; Bolognesi A.; Polito L.; De Gast G.C.
Ber‐H2 (anti‐CD30)‐saporin immunotoxin: a new tool for the the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation
1992 Tazzari P.L.; Bolognesi A.; Totero D.d.; Falini B.; Lemoli R.M.; Soria M.R.; Pileri S.; Gobbi M.; Stein H.; Flenghi L.; Martelli M.F.; Stirpe F.
Binding and intracellular routing of the plant-toxic lectins, lanceolin and stenodactylin
2010 Battelli M.G.; Scicchitano V.; Polito L.; Farini V.; Barbieri L.; Bolognesi A.
Bouganin, an attractive weapon for immunotoxins
2018 bortolotti massimo; bolognesi andrea; polito letizia
Bright oligothiophene N-succinimidyl esters for efficient fluorescent labeling of proteins and oligonucleotides.
2006 Barbarella G.; Zambianchi M.; Ventola A.; Fabiano E.; Della Sala F.; Gigli G.; Anni M.; Bolognesi A.; Polito L.; Naldi M.; Capobianco M.
CD38 as a target of IB4 mAb carrying saporin-S6: Design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia
2005 Bolognesi A.; Polito L.; Farini V.; Bortolotti M.; Tazzari P.L.; Ratta M.; Ravaioli A.; Horenstein A.L.; Stirpe F.; Battelli M.G.; Malavasi F.
Cell interaction of the type 1 RIP Saporin
2008 V. Scicchitano; L. Polito; M. Bortolotti; A. Bolognesi; M.G. Battelli
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
(ClO4)2: Metallodrug Nanocontainer Delivery and Membrane Lipidomics of a Neuroblastoma Cell Line Coupled with a Liposome Biomimetic Model Focusing on Fatty Acid Reactivity | Toniolo, Gianluca; Louka, Maria; Menounou, Georgia; Fantoni, Nicolò Zuin; Mitrikas, George; Efthi...miadou, Eleni K.; Masi, Annalisa; Bortolotti, Massimo; Polito, Letizia; Bolognesi, Andrea; Kellett, Andrew; Ferreri, Carla; Chatgilialoglu, Chryssostomos | 2018-01-01 | ACS OMEGA | - | 1.01 Articolo in rivista | ACS 2018.pdf |
A new potent and selective anti-lymphocytes-immunotoxin for the treatment of GVHD and lymphocyte-derived neoplasms | Polito L.; Bortolotti M.; Pedrazzi M.; Farini V.; Bolognesi A. | 2009-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
A systemic antiviral resistance-inducing protein isolated from Clerodendrum inerme Gaertn. is a polynucleotide:adenosine glycosidase (ribosome-inactivating protein) | Olivieri F.; Prasad V.; Valbonesi P.; Srivastava S.; Ghosal-Chowdhury P.; Barbieri L.; Bolognesi ...A.; Stirpe F. | 1996-01-01 | FEBS LETTERS | - | 1.01 Articolo in rivista | - |
Activities associated with the presence of ribosome-inactivating proteins increase in senescent and stressed leaves | Stirpe F.; Barbieri L.; Gorini P.; Valbonesi P.; Bolognesi A.; Polito L. | 1996-01-01 | FEBS LETTERS | - | 1.01 Articolo in rivista | - |
An epstein-barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins | Tazzari P.L.; De Totero D.; Bolognesi A.; Testoni N.; Pileri S.; Roncella S.; Reato G.; Stein H.;... Gobbi M.; Stirpe F. | 1999-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice | Terenzi A.; Bolognesi A.; Pasqualucci L.; Flenghi L.; Pileri S.; Stein H.; Marshall K.; Bigerna B....; Polito L.; Tazzari P.L.; Martelli M.F.; Stirpe F.; Falini B. | 1996-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering? | Zanello A.; Bortolotti M.; Maiello S.; Bolognesi A.; Polito L. | 2022-01-01 | FRONTIERS IN PHARMACOLOGY | - | 1.01 Articolo in rivista | 2022 FPhar-antiPD-L1.pdf |
Anti-tumor activity of Epratuzumab/saporin-S6. | Bortolotti M.; Polito L; Farini V; Pedrazzi M; Battelli MG; Bolognesi A. | 2012-01-01 | THE AMERICAN JOURNAL OF PATHOLOGY | Elsevier | 4.02 Riassunto (Abstract) | - |
Antibody conjugates for sarcoma therapy: How far along are we? | Polito L.; Calafato G.; Bortolotti M.; Chiarelli Olivari C.; Maiello S.; Bolognesi A. | 2021-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | 2021 biomedicines.pdf |
Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1 | Polito, Letizia; Bortolotti, Massimo; Pedrazzi, Manuela; Mercatelli, Daniele; Battelli, Maria Giu...lia; Bolognesi, Andrea | 2016-01-01 | PHYTOMEDICINE | - | 1.01 Articolo in rivista | Phytomedicine.pdf |
Assessing potential health threats by monitoring poison control centre data: a new alert in Italy concerning toxic concentrations of ricin in fertilizers | Franca Davanzo; Andrea Bolognesi; Laura Settimi | 2019-01-01 | CLINICAL TOXICOLOGY | - | 1.06 Abstract in rivista | - |
ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells. | Polito L.; Bortolotti M.; Farini V.; Pedrazzi M.; Tazzari P.L.; Bolognesi A. | 2009-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
B-b10 (Anti-CD25)-saporin immunotoxin—a possible tool in graft-versus-host disease treatment1 | Tazzari P.L.; Bolognesi A.; De Totero D.; Pileri S.; Conte R.; Wijdenes J.; Herve P.; Soria M.; S...tirpe F.; Gobbi M. | 1992-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease | Vooijs W.C.; Otten H.G.; Van Vliet M.; Van Dijk A.J.G.; De Weger R.A.; De Boer M.; Bohlen H.; Bol...ognesi A.; Polito L.; De Gast G.C. | 1997-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
Ber‐H2 (anti‐CD30)‐saporin immunotoxin: a new tool for the the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation | Tazzari P.L.; Bolognesi A.; Totero D.d.; Falini B.; Lemoli R.M.; Soria M.R.; Pileri S.; Gobbi M.;... Stein H.; Flenghi L.; Martelli M.F.; Stirpe F. | 1992-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Binding and intracellular routing of the plant-toxic lectins, lanceolin and stenodactylin | Battelli M.G.; Scicchitano V.; Polito L.; Farini V.; Barbieri L.; Bolognesi A. | 2010-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | - | 1.01 Articolo in rivista | - |
Bouganin, an attractive weapon for immunotoxins | bortolotti massimo; bolognesi andrea; polito letizia | 2018-01-01 | TOXINS | - | 1.01 Articolo in rivista | 2018 Toxins.pdf |
Bright oligothiophene N-succinimidyl esters for efficient fluorescent labeling of proteins and oligonucleotides. | Barbarella G.; Zambianchi M.; Ventola A.; Fabiano E.; Della Sala F.; Gigli G.; Anni M.; Bolognesi... A.; Polito L.; Naldi M.; Capobianco M. | 2006-01-01 | BIOCONJUGATE CHEMISTRY | - | 1.01 Articolo in rivista | - |
CD38 as a target of IB4 mAb carrying saporin-S6: Design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia | Bolognesi A.; Polito L.; Farini V.; Bortolotti M.; Tazzari P.L.; Ratta M.; Ravaioli A.; Horenstei...n A.L.; Stirpe F.; Battelli M.G.; Malavasi F. | 2005-01-01 | JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS | - | 1.01 Articolo in rivista | - |
Cell interaction of the type 1 RIP Saporin | V. Scicchitano; L. Polito; M. Bortolotti; A. Bolognesi; M.G. Battelli | 2008-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |